Back to discover
Disease
Enterobacteriaceae Infections
Late-stage therapeutic developmentEmerging research
1
Publications
10
Clinical trials
2025
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Ecological dynamics of Enterobacteriaceae in the human gut microbiome across global populations.
Research2025-01-10Nature microbiology
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 3 clinical trials with recent milestones.
Major developments
Major clinical milestoneImportant
Primary completion2026-05-01
Major clinical milestoneImportant
Primary completion2026-08-01
Clinical MilestonesViewHide
Recently completed
- 2026-08-01A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant OrganismsPrimary completion
- 2026-05-01Fecal Transplantation to Eradicate Colonizing Emergent SuperbugsPrimary completion
- 2026-03-18Faecal Microbiota Transplantation to Eradicate Gut Colonisation From Carbapenem-resistant Enterobacteriaceae: a Randomised Controlled TrialPrimary completion
Activity timeline3
- 2026-08-01ClinicalA Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant OrganismsPrimary completion
- 2026-05-01ClinicalFecal Transplantation to Eradicate Colonizing Emergent SuperbugsPrimary completion
- 2026-03-18ClinicalFaecal Microbiota Transplantation to Eradicate Gut Colonisation From Carbapenem-resistant Enterobacteriaceae: a Randomised Controlled TrialPrimary completion
Clinical trials
The current development programme across all trial phases.
Clinical programme
10
4
5
3
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes2
- Enterobacteriaceae1
- Gastrointestinal Microbiome1
Leading journals1
- Nature microbiology1
Leading researchers6
- Almeida A1
- Almeida AS1
- da Silva AC1
- Patil KR1
- Yin Q1
- Zorrilla F1
Affiliations (unnormalised)3
- College of Public Health1
- GIMM - Gulbenkian Institute for Molecular Medicine1
- University of Cambridge1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Infections with bacteria of the family ENTEROBACTERIACEAE.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.